Rakipovski G, Rolin B, Nohr J, Klewe I, Frederiksen KS, Augustin R, et al
Ishibashi Y, Matsui T, Takeuchi M, Yamagishi S: Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression
Participants in the retatrutide 4/8/12 mg group most frequently reported improved mobility or ability to perform physical activity (n = 19
More real world data suggests that GLP-1 drugs, which are reputed to aid the bodys cancer killing cells, may reduce the risk of colorectal, prostate, and liver cancer, too, says Drucker
Anxiety, depression, and the microbiome: a role for gut peptides
supplement potency and purity vary significantly Safety monitoring : Prescription drugs have mandatory adverse event reporting